A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion | Reuters
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceuticals found liable in New York opioid trial
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva Offers Update On Operations In Israel :: Generics Bulletin
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Israel enters medical cannabis market with new partnership | Reuters
Israel-based Teva settles opioid lawsuit with San Francisco for $45M
Teva Pharmaceutical Industries – The Forward
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Teva buys rights for Israeli co Biolojic's asthma treatment - Globes
Teva Pharmaceutical Industries | World Economic Forum
